COMMUNIQUÉS West-GlobeNewswire

TAP Sleep Care Secures Full Medicare Portfolio Coverage: Nylon flexTAP® Receives PDAC Approval under E0486
01/12/2025
DALLAS, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Airway Management, the innovator behind TAP Sleep Care and a leader in advanced oral appliance therapy, today announced that its groundbreaking Nylon flexTAP ® has received [...]
EssilorLuxottica crée un Comité consultatif scientifique pour accompagner son accélération sur l'innovation
01/12/2025
EssilorLuxottica crée un Comité consultatif scientifique pour accompagner son accélération sur l'innovation Paris, France (1 er décembre 2025) – EssilorLuxottica a annoncé la création de son Comité consultatif [...]
EssilorLuxottica creates Scientific Advisory Committee to accelerate the next era of innovation
01/12/2025
EssilorLuxottica creates Scientific Advisory Committee to accelerate the next era of innovation Paris, France (1 December 2025) – EssilorLuxottica announced the creation of its Scientific Advisory Committee, bringing [...]
GROUPE SAFE - Résultats annuels 2024 - Mise à disposition du rapport annuel 2024
01/12/2025
Résultats annuels 2024 Mise à disposition du rapport annuel 2024 Fleurieux-sur-l’Arbresle – France – 1 er décembre 2025 - Safe (FR001400ZU25 – ALSAF) (la « Société ») annonce ses résultats annuels et avoir mis à la [...]
XENOVIEW® 3T coil passes Philips compatibility testing
01/12/2025
Polarean’s FDA cleared coil achieves important milestone, expanding clinical reach DURHAM, NC and LONDON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in [...]
Kriya appoints Greg Di Russo, MD as Chief Medical Officer
01/12/2025
Accomplished biopharma executive with deep experience leading the development of complex biologics and gene therapies at multiple small and large biopharmaceutical companies RESEARCH TRIANGLE PARK, N.C., Dec. 01, 2025 ( [...]
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors
01/12/2025
CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, [...]
Centre For Neuro Skills Announces Grand Opening for New Plano Clinic; Fifth in Texas
01/12/2025
New 20,000+ square foot facility expands cutting-edge brain injury care in North Texas PLANO, Texas, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Centre for Neuro Skills (CNS) , a premier provider of treatment for traumatic and [...]
ALK appoints Edward Jordan as new EVP and head of Commercial Operations North America
01/12/2025
ALK (ALKB:DC / OMX: ALK B) today announced the appointment of Edward Jordan as new Executive Vice President (EVP) and head of Commercial Operations in North America as per 5 January 2026. Edward Jordan succeeds Søren [...]
Evestia Clinical Announces New Strategic Advisory Board to Advance Specialist CRO Capabilities Worldwide
01/12/2025
New advisory board brings further world-class expertise in oncology, neurology, geographic market expansion, and AI enabled clinical trial delivery to support biotech innovators LETCHWORTH GARDEN CITY, United Kingdom, [...]
New Genome BC Funded Project Aims to Bring BC Closer to Ending HIV Transmission
01/12/2025
VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- World AIDS Day 2025 — British Columbia has made remarkable progress in reducing HIV transmission and researchers now believe the province is closer than [...]
€150 million agreement between EIB and Angelini Ventures to finance European startups
01/12/2025
This is the first agreement signed by the EIB with a corporate venture capital in the healthcare sector, and is part of the EU strategy to support the development of innovative companies across the continent. Angelini [...]
REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025
01/12/2025
Press release – No. 17 / 2025 REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025 Copenhagen, Denmark, December 1, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company [...]
BioNTX Concludes Landmark iC³® 2025 Summit — Announces 2026 Summit in Arlington, Texas
01/12/2025
DALLAS, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The 2025 iC³® Life Science & Healthcare Innovation Summit, hosted by BioNTX , concluded on September 16–17 at the Hilton Anatole in Dallas, marking more than a decade of [...]
Hapbee Delivers Record Profit of USD $1.43 Million in Second Straight Quarter of Growth, Posts Q3 Revenue of $446,897 and Earnings of 0.5 Cents Per Share
01/12/2025
Record-setting financial performance driven by new management team grows recurring revenue position with 188% subscriber growth since Q1, reducing liabilities while advancing investments into Hapbee’s next-generation [...]
Longeveron New MRI Biomarker Data Linking Neuroinflammation to Clinical Outcomes in Patients with Mild Alzheimer’s Disease Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025)
01/12/2025
Results obtained in the Phase 2 placebo-controlled CLEAR-MIND clinical trial showed that treatment with stem cell therapy laromestrocel was associated with a reduction in MRI measured neuroinflammation compared to [...]
Plus Therapeutics to Present ReSPECT Phase 1 Dose Escalation Study Results for Leptomeningeal Metastases at the 2025 San Antonio Breast Cancer Symposium
01/12/2025
Study findings to be featured in a poster spotlight presentation HOUSTON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/12/2025
CLEVELAND, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in [...]
Biogen and Stoke Therapeutics Announce Presentations at the 2025 American Epilepsy Society Annual Meeting
01/12/2025
New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in patients with Dravet syndrome treated with zorevunersen support the potential for disease [...]

Pages